Prime Therapeutics closes $1.35 billion Magellan Rx acquisition
EAGAN, Minn. – Leading pharmacy benefit manager Prime Therapeutics (Prime) has finalized the previously announced acquisition of Magellan Rx Management, (Magellan Rx), the pharmacy division of Magellan Health, from Centene Corporation. The agreement unites Prime’s strong foundation of pharmacy benefit management (PBM) capabilities with Magellan Rx’s industry-leading total specialty drug management expertise to create a
